Stay updated on Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.

Latest updates to the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial for cenobamate, which included eligibility criteria, dosing regimens, and study design. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference39%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and changed the date from 2025-03-25 to 2025-01-14.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date (2025-03-25), replacing the previous version (v2.14.2) and date (2025-01-14).SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.